Growth Metrics

Vericel (VCEL) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Vericel (VCEL) over the last 16 years, with Q3 2025 value amounting to $453.3 million.

  • Vericel's Liabilities and Shareholders Equity rose 1610.35% to $453.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 1818.06%. This contributed to the annual value of $432.7 million for FY2024, which is 2235.64% up from last year.
  • As of Q3 2025, Vericel's Liabilities and Shareholders Equity stood at $453.3 million, which was up 1610.35% from $435.6 million recorded in Q2 2025.
  • Vericel's 5-year Liabilities and Shareholders Equity high stood at $453.3 million for Q3 2025, and its period low was $211.5 million during Q1 2021.
  • Over the past 5 years, Vericel's median Liabilities and Shareholders Equity value was $310.7 million (recorded in 2023), while the average stood at $317.1 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 5130.1% in 2021, then soared by 1030.44% in 2022.
  • Vericel's Liabilities and Shareholders Equity (Quarter) stood at $243.7 million in 2021, then grew by 12.02% to $273.0 million in 2022, then rose by 29.54% to $353.7 million in 2023, then increased by 22.36% to $432.7 million in 2024, then increased by 4.75% to $453.3 million in 2025.
  • Its Liabilities and Shareholders Equity was $453.3 million in Q3 2025, compared to $435.6 million in Q2 2025 and $424.6 million in Q1 2025.